Showing posts with label ACTH. Show all posts
Showing posts with label ACTH. Show all posts
Wednesday, 4 December 2013
PPID: Equine endocrinology researchers revise guidelines for "Cushings" tests for horses
Equine Cushings Disease or pituitary pars intermedia dysfunction (PPID) has been easy to identify, with overt signs like a long coat. Underlying PPID is now being identified in younger horses and in horses that show none of the typical signs. Researchers say that an episode of otherwise-unexplained laminitis may be their first and only clue.
Edited from press release
Equine pituitary pars
Monday, 3 September 2012
Autumn Laminitis: Prepare to Prevent--Instead of Treat--Seasonal Flair-Ups of Endocrine Conditions in Horses
This is what a foot looks like after laminitis...could this damage and deformation have been prevented? In Great Britain, a study found that 43 percent of horse owners waited more than a week after suspecting laminitis before seeking veterinary intervention. (Boehringer Ingelheim photo)
If Labor Day is over, can autumn laminitis season be far behind?
This summer's drought has been relieved
Labels:
ACTH,
autumn,
Boehringer,
Cushings,
fall,
founder,
Insulin,
laminitis,
PPID,
prevention,
resistance
Thursday, 3 November 2011
Prascend® PPID (Equine Cushings Disease) Treatment Approved by FDA for US Horses
Maybe I'm biased, but I thought that the CSI (Cushings Scene Investigation) ad run by Boehringer-Ingelheim Vetmedica in British horse magazines was the most clever horse ad so far this year. It heralded the introduction of Prascend to treat Cushings-suffering horses; Prascend will soon be available in the USA.
The following press release is not an ad, it is published here as a "
Labels:
ACTH,
Boehringer,
Cushings,
disease,
dysfunction,
endocrine,
Equine,
Fran,
Ingelheim,
Jurga,
laminitis,
medication,
metabolic,
pars,
pituitary,
PPID,
Prascend,
syndrome,
treatment
Subscribe to:
Posts (Atom)